GLP-1 Market
LLY $1382.75 ▼ -2.3% NVO $39.43 ▼ -3.1% PFE $28.06 ▼ -1.4% VKTX $26.17 ▼ -2.6% KLRA $11.79 ▼ -3.4% GPCR $17.36 ▼ -4.5% RHHBY $59.52 ▼ -1.2%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Sildenafil therapy

Company
Benha University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 19, 2026

Trial details
  • Terminated NCT NCT00492531

    Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 74 participants Est. completion 2009-10 9 sites
    Other conditions: Sickle Cell Disease, Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT00624273

    Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis

    Not yet reported Charite University, Berlin, Germany 17 participants Est. completion 2007-02 1 site
    Other conditions: Active Digital Ulcers
    View official trial listing →
  • No Longer Available NCT NCT00866983

    Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • No Longer Available NCT NCT00878943

    Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 5 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT00906269

    Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer

    Not yet reported Hartford Hospital 100 participants Est. completion 2021-01 1 site
    Other conditions: Impotence, Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00946114

    To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 32 participants Est. completion 2009-03 2 sites
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • No Longer Available NCT NCT01582438

    An Open Label Access Study For Subjects Who Completed A1481156

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01800292

    Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.

    Not yet reported University of Arizona 9 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hypertension, Pulmonary Artery, Ventricular Dysfunction, Left
    View official trial listing →
  • No Longer Available NCT NCT01897740

    Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT02277132

    The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)

    Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 216 participants Est. completion 2018-07-19 10 sites
    Other conditions: Fetal Growth Restriction
    View official trial listing →
  • Terminated NCT NCT02442492

    Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction

    Not yet reported, Not yet reported University of British Columbia 21 participants Est. completion 2019-04 5 sites
    Other conditions: Intrauterine Growth Restriction (IUGR), Fetal Growth Restriction (FGR)
    View official trial listing →
  • Completed NCT NCT07293156

    Impact of Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil on Diabetic Erectile Dysfunction.

    Not yet reported Benha University 60 participants Est. completion 2026-11-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabete Mellitus, Pilates Exercise, Pelvic Floor Muscle Exercise
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.